Global Pre-Implantation Genetic Diagnosis (PGD) Market Research Report 2024(Status and Outlook)
Report Overview:
Pre-Implantation Genetic Diagnosis (PGD) is the genetic profiling of embryos prior to implantation (as a form of embryo profiling), and sometimes even of oocytes prior to fertilization.
The Global Pre-Implantation Genetic Diagnosis (PGD) Market Size was estimated at USD 106.72 million in 2023 and is projected to reach USD 137.39 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
This report provides a deep insight into the global Pre-Implantation Genetic Diagnosis (PGD) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pre-Implantation Genetic Diagnosis (PGD) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pre-Implantation Genetic Diagnosis (PGD) market in any manner.
Global Pre-Implantation Genetic Diagnosis (PGD) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Genea Limited
Quest Diagnostics
Illumina, Inc.
Natera, Inc.
Cooper Medical, Inc.
LabCorp
California Pacific Medical Center (CPMC)
Thermo Fisher Scientific Inc.
IGENOMIX
Reproductive Genetic Innovations
CombiMatrix
Market Segmentation (by Type)
Chromosomal Abnormalities
X-linked Diseases
Freeze Embryo Testing
Aneuploidy Screening
HLA
Others
Market Segmentation (by Application)
Stem Cell Therapy
IVF Prognosis
Late-Onset Genetic Disorders
Inherited Genetic Disease
Others
Geographic Segmentation
Pre-Implantation Genetic Diagnosis (PGD) is the genetic profiling of embryos prior to implantation (as a form of embryo profiling), and sometimes even of oocytes prior to fertilization.
The Global Pre-Implantation Genetic Diagnosis (PGD) Market Size was estimated at USD 106.72 million in 2023 and is projected to reach USD 137.39 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
This report provides a deep insight into the global Pre-Implantation Genetic Diagnosis (PGD) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pre-Implantation Genetic Diagnosis (PGD) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pre-Implantation Genetic Diagnosis (PGD) market in any manner.
Global Pre-Implantation Genetic Diagnosis (PGD) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Genea Limited
Quest Diagnostics
Illumina, Inc.
Natera, Inc.
Cooper Medical, Inc.
LabCorp
California Pacific Medical Center (CPMC)
Thermo Fisher Scientific Inc.
IGENOMIX
Reproductive Genetic Innovations
CombiMatrix
Market Segmentation (by Type)
Chromosomal Abnormalities
X-linked Diseases
Freeze Embryo Testing
Aneuploidy Screening
HLA
Others
Market Segmentation (by Application)
Stem Cell Therapy
IVF Prognosis
Late-Onset Genetic Disorders
Inherited Genetic Disease
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pre-Implantation Genetic Diagnosis (PGD) Market
- Overview of the regional outlook of the Pre-Implantation Genetic Diagnosis (PGD) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pre-Implantation Genetic Diagnosis (PGD)
1.2 Key Market Segments
1.2.1 Pre-Implantation Genetic Diagnosis (PGD) Segment by Type
1.2.2 Pre-Implantation Genetic Diagnosis (PGD) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET COMPETITIVE LANDSCAPE
3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Manufacturers (2019-2024)
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Manufacturers (2019-2024)
3.3 Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pre-Implantation Genetic Diagnosis (PGD) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pre-Implantation Genetic Diagnosis (PGD) Sales Sites, Area Served, Product Type
3.6 Pre-Implantation Genetic Diagnosis (PGD) Market Competitive Situation and Trends
3.6.1 Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pre-Implantation Genetic Diagnosis (PGD) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) INDUSTRY CHAIN ANALYSIS
4.1 Pre-Implantation Genetic Diagnosis (PGD) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Type (2019-2024)
6.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
6.4 Global Pre-Implantation Genetic Diagnosis (PGD) Price by Type (2019-2024)
7 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Sales by Application (2019-2024)
7.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) by Application (2019-2024)
7.4 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2019-2024)
8 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SEGMENTATION BY REGION
8.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region
8.2 North America
8.2.1 North America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.1.2 Roche Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Genea Limited
9.2.1 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.2.2 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.2.4 Genea Limited Business Overview
9.2.5 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
9.2.6 Genea Limited Recent Developments
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.3.2 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.3.4 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
9.3.5 Quest Diagnostics Business Overview
9.3.6 Quest Diagnostics Recent Developments
9.4 Illumina, Inc.
9.4.1 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.4.2 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.4.4 Illumina, Inc. Business Overview
9.4.5 Illumina, Inc. Recent Developments
9.5 Natera, Inc.
9.5.1 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.5.2 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.5.4 Natera, Inc. Business Overview
9.5.5 Natera, Inc. Recent Developments
9.6 Cooper Medical, Inc.
9.6.1 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.6.2 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.6.4 Cooper Medical, Inc. Business Overview
9.6.5 Cooper Medical, Inc. Recent Developments
9.7 LabCorp
9.7.1 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.7.2 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.7.4 LabCorp Business Overview
9.7.5 LabCorp Recent Developments
9.8 California Pacific Medical Center (CPMC)
9.8.1 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.8.2 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.8.4 California Pacific Medical Center (CPMC) Business Overview
9.8.5 California Pacific Medical Center (CPMC) Recent Developments
9.9 Thermo Fisher Scientific Inc.
9.9.1 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.9.2 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.9.4 Thermo Fisher Scientific Inc. Business Overview
9.9.5 Thermo Fisher Scientific Inc. Recent Developments
9.10 IGENOMIX
9.10.1 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.10.2 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.10.4 IGENOMIX Business Overview
9.10.5 IGENOMIX Recent Developments
9.11 Reproductive Genetic Innovations
9.11.1 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.11.2 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.11.4 Reproductive Genetic Innovations Business Overview
9.11.5 Reproductive Genetic Innovations Recent Developments
9.12 CombiMatrix
9.12.1 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.12.2 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.12.4 CombiMatrix Business Overview
9.12.5 CombiMatrix Recent Developments
10 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET FORECAST BY REGION
10.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast
10.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country
10.2.3 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region
10.2.4 South America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pre-Implantation Genetic Diagnosis (PGD) by Type (2025-2030)
11.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pre-Implantation Genetic Diagnosis (PGD) by Type (2025-2030)
11.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Application (2025-2030)
11.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) Forecast by Application
11.2.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pre-Implantation Genetic Diagnosis (PGD)
1.2 Key Market Segments
1.2.1 Pre-Implantation Genetic Diagnosis (PGD) Segment by Type
1.2.2 Pre-Implantation Genetic Diagnosis (PGD) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET COMPETITIVE LANDSCAPE
3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Manufacturers (2019-2024)
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Manufacturers (2019-2024)
3.3 Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pre-Implantation Genetic Diagnosis (PGD) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pre-Implantation Genetic Diagnosis (PGD) Sales Sites, Area Served, Product Type
3.6 Pre-Implantation Genetic Diagnosis (PGD) Market Competitive Situation and Trends
3.6.1 Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pre-Implantation Genetic Diagnosis (PGD) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) INDUSTRY CHAIN ANALYSIS
4.1 Pre-Implantation Genetic Diagnosis (PGD) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Type (2019-2024)
6.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
6.4 Global Pre-Implantation Genetic Diagnosis (PGD) Price by Type (2019-2024)
7 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Sales by Application (2019-2024)
7.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) by Application (2019-2024)
7.4 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2019-2024)
8 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SEGMENTATION BY REGION
8.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region
8.2 North America
8.2.1 North America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.1.2 Roche Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Genea Limited
9.2.1 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.2.2 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.2.4 Genea Limited Business Overview
9.2.5 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
9.2.6 Genea Limited Recent Developments
9.3 Quest Diagnostics
9.3.1 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.3.2 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.3.4 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
9.3.5 Quest Diagnostics Business Overview
9.3.6 Quest Diagnostics Recent Developments
9.4 Illumina, Inc.
9.4.1 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.4.2 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.4.4 Illumina, Inc. Business Overview
9.4.5 Illumina, Inc. Recent Developments
9.5 Natera, Inc.
9.5.1 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.5.2 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.5.4 Natera, Inc. Business Overview
9.5.5 Natera, Inc. Recent Developments
9.6 Cooper Medical, Inc.
9.6.1 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.6.2 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.6.4 Cooper Medical, Inc. Business Overview
9.6.5 Cooper Medical, Inc. Recent Developments
9.7 LabCorp
9.7.1 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.7.2 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.7.4 LabCorp Business Overview
9.7.5 LabCorp Recent Developments
9.8 California Pacific Medical Center (CPMC)
9.8.1 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.8.2 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.8.4 California Pacific Medical Center (CPMC) Business Overview
9.8.5 California Pacific Medical Center (CPMC) Recent Developments
9.9 Thermo Fisher Scientific Inc.
9.9.1 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.9.2 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.9.4 Thermo Fisher Scientific Inc. Business Overview
9.9.5 Thermo Fisher Scientific Inc. Recent Developments
9.10 IGENOMIX
9.10.1 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.10.2 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.10.4 IGENOMIX Business Overview
9.10.5 IGENOMIX Recent Developments
9.11 Reproductive Genetic Innovations
9.11.1 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.11.2 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.11.4 Reproductive Genetic Innovations Business Overview
9.11.5 Reproductive Genetic Innovations Recent Developments
9.12 CombiMatrix
9.12.1 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Basic Information
9.12.2 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Overview
9.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Market Performance
9.12.4 CombiMatrix Business Overview
9.12.5 CombiMatrix Recent Developments
10 PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET FORECAST BY REGION
10.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast
10.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country
10.2.3 Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region
10.2.4 South America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pre-Implantation Genetic Diagnosis (PGD) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pre-Implantation Genetic Diagnosis (PGD) by Type (2025-2030)
11.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pre-Implantation Genetic Diagnosis (PGD) by Type (2025-2030)
11.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Forecast by Application (2025-2030)
11.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) Forecast by Application
11.2.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pre-Implantation Genetic Diagnosis (PGD) Market Size Comparison by Region (M USD)
Table 5. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2022)
Table 10. Global Market Pre-Implantation Genetic Diagnosis (PGD) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pre-Implantation Genetic Diagnosis (PGD) Sales Sites and Area Served
Table 12. Manufacturers Pre-Implantation Genetic Diagnosis (PGD) Product Type
Table 13. Global Pre-Implantation Genetic Diagnosis (PGD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pre-Implantation Genetic Diagnosis (PGD)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
Table 22. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Type (K Units)
Table 23. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (M USD)
Table 24. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Type (2019-2024)
Table 25. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Type (2019-2024)
Table 26. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) by Type (2019-2024)
Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Type (2019-2024)
Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Application
Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
Table 31. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Application (2019-2024) & (K Units)
Table 32. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application (2019-2024)
Table 33. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Application (2019-2024) & (M USD)
Table 34. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2024)
Table 35. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2019-2024)
Table 36. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2019-2024) & (K Units)
Table 37. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region (2019-2024)
Table 38. North America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2019-2024) & (K Units)
Table 41. South America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2019-2024) & (K Units)
Table 43. Roche Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 44. Roche Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 45. Roche Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 50. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 51. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Genea Limited Business Overview
Table 53. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
Table 54. Genea Limited Recent Developments
Table 55. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 56. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 57. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
Table 59. Quest Diagnostics Business Overview
Table 60. Quest Diagnostics Recent Developments
Table 61. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 62. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 63. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Illumina, Inc. Business Overview
Table 65. Illumina, Inc. Recent Developments
Table 66. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 67. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 68. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Natera, Inc. Business Overview
Table 70. Natera, Inc. Recent Developments
Table 71. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 72. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 73. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Cooper Medical, Inc. Business Overview
Table 75. Cooper Medical, Inc. Recent Developments
Table 76. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 77. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 78. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. LabCorp Business Overview
Table 80. LabCorp Recent Developments
Table 81. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 82. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 83. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. California Pacific Medical Center (CPMC) Business Overview
Table 85. California Pacific Medical Center (CPMC) Recent Developments
Table 86. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 87. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 88. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Thermo Fisher Scientific Inc. Business Overview
Table 90. Thermo Fisher Scientific Inc. Recent Developments
Table 91. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 92. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 93. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. IGENOMIX Business Overview
Table 95. IGENOMIX Recent Developments
Table 96. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 97. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 98. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Reproductive Genetic Innovations Business Overview
Table 100. Reproductive Genetic Innovations Recent Developments
Table 101. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 102. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 103. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. CombiMatrix Business Overview
Table 105. CombiMatrix Recent Developments
Table 106. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Pre-Implantation Genetic Diagnosis (PGD) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pre-Implantation Genetic Diagnosis (PGD) Market Size Comparison by Region (M USD)
Table 5. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2022)
Table 10. Global Market Pre-Implantation Genetic Diagnosis (PGD) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pre-Implantation Genetic Diagnosis (PGD) Sales Sites and Area Served
Table 12. Manufacturers Pre-Implantation Genetic Diagnosis (PGD) Product Type
Table 13. Global Pre-Implantation Genetic Diagnosis (PGD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pre-Implantation Genetic Diagnosis (PGD)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
Table 22. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Type (K Units)
Table 23. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (M USD)
Table 24. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Type (2019-2024)
Table 25. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Type (2019-2024)
Table 26. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) by Type (2019-2024)
Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Type (2019-2024)
Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) by Application
Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
Table 31. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Application (2019-2024) & (K Units)
Table 32. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application (2019-2024)
Table 33. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Application (2019-2024) & (M USD)
Table 34. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2024)
Table 35. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2019-2024)
Table 36. Global Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2019-2024) & (K Units)
Table 37. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region (2019-2024)
Table 38. North America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2019-2024) & (K Units)
Table 41. South America Pre-Implantation Genetic Diagnosis (PGD) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales by Region (2019-2024) & (K Units)
Table 43. Roche Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 44. Roche Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 45. Roche Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 50. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 51. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Genea Limited Business Overview
Table 53. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
Table 54. Genea Limited Recent Developments
Table 55. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 56. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 57. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) SWOT Analysis
Table 59. Quest Diagnostics Business Overview
Table 60. Quest Diagnostics Recent Developments
Table 61. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 62. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 63. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Illumina, Inc. Business Overview
Table 65. Illumina, Inc. Recent Developments
Table 66. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 67. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 68. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Natera, Inc. Business Overview
Table 70. Natera, Inc. Recent Developments
Table 71. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 72. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 73. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Cooper Medical, Inc. Business Overview
Table 75. Cooper Medical, Inc. Recent Developments
Table 76. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 77. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 78. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. LabCorp Business Overview
Table 80. LabCorp Recent Developments
Table 81. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 82. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 83. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. California Pacific Medical Center (CPMC) Business Overview
Table 85. California Pacific Medical Center (CPMC) Recent Developments
Table 86. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 87. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 88. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Thermo Fisher Scientific Inc. Business Overview
Table 90. Thermo Fisher Scientific Inc. Recent Developments
Table 91. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 92. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 93. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. IGENOMIX Business Overview
Table 95. IGENOMIX Recent Developments
Table 96. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 97. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 98. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Reproductive Genetic Innovations Business Overview
Table 100. Reproductive Genetic Innovations Recent Developments
Table 101. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Basic Information
Table 102. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product Overview
Table 103. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. CombiMatrix Business Overview
Table 105. CombiMatrix Recent Developments
Table 106. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Pre-Implantation Genetic Diagnosis (PGD) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pre-Implantation Genetic Diagnosis (PGD)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD), 2019-2030
Figure 5. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) (2019-2030)
Figure 6. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (M USD)
Figure 11. Pre-Implantation Genetic Diagnosis (PGD) Sales Share by Manufacturers in 2023
Figure 12. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Manufacturers in 2023
Figure 13. Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pre-Implantation Genetic Diagnosis (PGD) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type
Figure 18. Sales Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type (2019-2024)
Figure 19. Sales Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type in 2023
Figure 20. Market Size Share of Pre-Implantation Genetic Diagnosis (PGD) by Type (2019-2024)
Figure 21. Market Size Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application
Figure 24. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application (2019-2024)
Figure 25. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application in 2023
Figure 26. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2024)
Figure 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application in 2023
Figure 28. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region (2019-2024)
Figure 30. North America Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2023
Figure 32. U.S. Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Pre-Implantation Genetic Diagnosis (PGD) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2023
Figure 37. Germany Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region in 2023
Figure 44. China Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 50. South America Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2023
Figure 51. Brazil Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Type (2025-2030)
Figure 65. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Application (2025-2030)
Figure 66. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Pre-Implantation Genetic Diagnosis (PGD)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD), 2019-2030
Figure 5. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (M USD) (2019-2030)
Figure 6. Global Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (M USD)
Figure 11. Pre-Implantation Genetic Diagnosis (PGD) Sales Share by Manufacturers in 2023
Figure 12. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Manufacturers in 2023
Figure 13. Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pre-Implantation Genetic Diagnosis (PGD) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type
Figure 18. Sales Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type (2019-2024)
Figure 19. Sales Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type in 2023
Figure 20. Market Size Share of Pre-Implantation Genetic Diagnosis (PGD) by Type (2019-2024)
Figure 21. Market Size Market Share of Pre-Implantation Genetic Diagnosis (PGD) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application
Figure 24. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application (2019-2024)
Figure 25. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Application in 2023
Figure 26. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2024)
Figure 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application in 2023
Figure 28. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region (2019-2024)
Figure 30. North America Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2023
Figure 32. U.S. Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Pre-Implantation Genetic Diagnosis (PGD) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Pre-Implantation Genetic Diagnosis (PGD) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2023
Figure 37. Germany Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region in 2023
Figure 44. China Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 50. South America Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Country in 2023
Figure 51. Brazil Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Pre-Implantation Genetic Diagnosis (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Type (2025-2030)
Figure 65. Global Pre-Implantation Genetic Diagnosis (PGD) Sales Forecast by Application (2025-2030)
Figure 66. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share Forecast by Application (2025-2030)
